The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: Case report

Pathologica

Volumn 98, Issue 2, 2006, Pages 156-159

  Vranic, Semir ^a   Kapur, L ^b   Foco, F ^a   Bilalovic, N ^a   Hainaut, P ^c  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b Institute for Genetic Engineering and Biotechnology   (Bosnia and Herzegovina)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Genes; Hereditary; Li Fraumeni syndrome; Neoplastic syndromes; TP53

Indexed keywords

PROTEIN P53;

ANAMNESIS; ARTICLE; BLOOD SAMPLING; BREAST FIBROADENOMA; CASE REPORT; EXON; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FRANCE; GENE MUTATION; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; MULTIPLE CANCER; RHABDOMYOSARCOMA; SCHOOL CHILD; SEQUENCE ANALYSIS; TUMOR BIOPSY;

BOSNIA-HERZEGOVINA; BREAST NEOPLASMS; CHILD; DNA, NEOPLASM; EXONS; FACIAL NEOPLASMS; FEMALE; FIBROADENOMA; GENES, P53; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; INTRONS; LI-FRAUMENI SYNDROME; LIP NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; ORBIT EVISCERATION; PEDIGREE; RHABDOMYOSARCOMA;

EID: 33746629350     PISSN: 00312983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Birch JM, Alston RD, McNally RJQ, Evans DGR, Kelsey AM, Harris M, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001;20:4621-8.
2. Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, et al. Li-Fraumeni and related syndromes: Correlation between tumour type, family structure and TP53 genotype. Cancer Res 2003;63:6643-50.
3. Hainaut P. Tumor-specific mutations in p53: The acid test. Nature Med 2002;8:21-3.
4. Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP. Germline p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001;10:83-7.
5. Varley JM. p53 review article: Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mut 2003;21:313-20.
6. Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer and other neoplasms. A familial syndrome? Ann Intern Med 1969;71:747-52.
7. Varley JM, Evans DGR, Birch JM. Li-Fraumeni syndrome - a molecular and clinical review. Br J Cancer 1997;76:1-14.
8. Eeles RA. Germline mutations in the TP53 gene. Cancer Surv 1995;25:101-23.
9. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994;54:1298-304.
10. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606-11.
11. Chompret A, Abel A, Stoppa-Lyonnet D, Brugieres L, Pages S, Feunteun J, et al. Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 2001;38:43-7.
12. Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network. Version 1.2005. Available at: www.nccn.org. Accessed 26 June 2005.
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
14. Parham DM, Eccles DM. Fibroadenoma with atypical giant cells occurring in Li-Fraumeni syndrome. Breast 2001;10:330-2.
15. Birch JM. The Li-Fraumeni syndrome and the role of TP53 mutations in predisposition to cancer. In: Eeles RA, Easton DF, Ponder B, Eng C, eds. Genetic Predisposition to Cancer. London: Arnold 2004, pp. 141-154.
16. Limacher JM, Frebourg T, Natarajan-Ame S, Bergerat JP. Two metachronous tumours in the radiotherapy fields of a patient with Li-Fraumeni Syndrome. Int J Cancer 2001;96:238-42.
17. Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr, et al. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 1995;56:608-15.
18. Kleihues P, Schauble B, Hausen zur A, Estebe J, Ohgaki H. Tumors associated with p53 germline mutation: a synopsis of 91 families. Am J Pathol 1997; 150:1-13.
19. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plumer WD Jr, Rados MS, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 1994;331:10-5.
20. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005;353:229-37.